Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1Phase 1/2 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5Neoplasms 2Prostatic Diseases 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Prostate-Specific Antigen × Clear all
NCT00853710 2025-11-20

Test Semiquantitative Prostate Specific Antigen (PSA)

Institut Curie

Phase NA Completed
94 enrolled
Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

NCT02933255 2024-05-31

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
24 enrolled 20 charts
Genitourinary

Prostatic Neoplasms

NCT02419846 2022-07-25

Informed Decision Making Intervention in Screening for Prostate Cancer of Predominantly African American Participants in a Community Outreach Program

Case Comprehensive Cancer Center

Phase NA Terminated
319 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT04063566 2021-10-15

ReIMAGINE Prostate Cancer Screening

University College, London

Phase NA Completed
309 enrolled
Genitourinary

Prostatic Neoplasms

NCT02710422 2019-09-11

MMEP

University of Miami

Phase 2 Terminated
24 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡